Metabolism of defined structured triglyceride particles compared to mixtures of medium and long chain triglycerides intravenously infused in dogs.
The present study aimed to determine whether including medium-chain fatty acids (MCFA) in specifically designed structured triglycerides (STG) with a MCFA in sn-1 and sn-3 positions and a long-chain (LC) FA in sn-2 position (MLM) would lead to different effects on plasma lipids and FA distribution into plasma and tissue lipids by comparison to a mixture of separate MCT and LCT molecules (MMM/LLL). The fatty acid (FA) composition was comparable in both lipid emulsions. Lipids were infused over 9h daily, in 2 groups of dogs (n = 6 each), for 28 days as a major component (55% of the non-protein energy intake) of total parenteral nutrition (TPN). Blood samples were obtained on specific days, before starting and just before stopping TPN. The concentration of plasma lipids was measured before starting and before stopping TPN on days 1, 2, 3, 4, 5, 8, 10, 12, 16 and 28. Biopsies were obtained from liver, muscle and adipose tissue 15 days before starting, and again on the day following cessation of TPN. In addition, the spleen was removed after the TPN period. FA composition in plasma and tissue lipids was analysed by gas liquid chromatography in different lipid components of plasma and tissues. No differences in either safety or tolerance parameters were detected between both lipid preparations. A lower rise of plasma TG (P < 0.05) was observed during MLM infusion, indicating a faster elimination rate of MLM vs MMM/LLL emulsion. In spite of the differences of TG molecules which would be assumed to affect the site of FA delivery and metabolic fate, FA distribution in phospholipids (PL) of hepatic and extrahepatic tissues did not substantially differ between both emulsions.
L. Deloyers Laboratory for Experimental Surgery, Université Libre de Bruxelles, Brussels, Belgium.
Ch
Ch
Simoens
R J
RJ
Deckelbaum
Y A
YA
Carpentier
D000818:Animals; D004285:Dogs / Q000097:blood*; D005217:Fat Emulsions, Intravenous / Q000737:chemistry* / Q000378:metabolism*; D005232:Fatty Acids, Volatile / Q000737:chemistry / Q000378:metabolism; D050356:Lipid Metabolism; D008055:Lipids / Q000097:blood / Q000737:chemistry*; D008099:Liver / Q000378:metabolism; D008297:Male; D009928:Organ Specificity; D010289:Parenteral Nutrition, Total; D011897:Random Allocation; D013997:Time Factors; D014018:Tissue Distribution; D014280:Triglycerides / Q000737:chemistry*
D005217:Fat Emulsions, Intravenous; D005232:Fatty Acids, Volatile; D008055:Lipids; D014280:Triglycerides